KT-621
KT621-HV-101
Phase 1 small_molecule completed
Quick answer
KT-621 for Healthy Participants Study is a Phase 1 program (small_molecule) at Kymera Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Kymera Therapeutics
- Indication
- Healthy Participants Study
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed